Literature DB >> 11564782

Histamine polarizes human dendritic cells into Th2 cell-promoting effector dendritic cells.

G Caron1, Y Delneste, E Roelandts, C Duez, J Y Bonnefoy, J Pestel, P Jeannin.   

Abstract

Allergic disorders are characterized by allergen-specific Th2-biased responses. Signals controlling Th2 cell polarization, especially those acting by polarizing dendritic cells (DC) into Th2-promoting DC (DC2), are not well known. Histamine, a mediator released by allergen-stimulated mast cells from allergic subjects, has been reported to activate human immature DC. We have therefore tested whether histamine affects DC polarization. We report here that histamine inhibits LPS-induced IL-12 production and polarizes uncommitted maturing DC into effector DC2. DC matured in the presence of histamine fail to produce IL-12 upon subsequent stimulation and prime Th2 responses, even in presence of IFN-gamma, a potent DC1-driving factor. All these effects are mediated through both H1 and H2 receptors. These data show that histamine is a potent DC2-polarizing factor and provide evidence for a novel mechanism that explains the initiation and maintenance of a predominant Th2 response in allergic disorders.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11564782     DOI: 10.4049/jimmunol.167.7.3682

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  48 in total

Review 1.  Programming dendritic cells to induce T(H)2 and tolerogenic responses.

Authors:  Bali Pulendran; Hua Tang; Santhakumar Manicassamy
Journal:  Nat Immunol       Date:  2010-07-20       Impact factor: 25.606

2.  Histamine promotes the development of monocyte-derived dendritic cells and reduces tumor growth by targeting the myeloid NADPH oxidase.

Authors:  Anna Martner; Hanna G Wiktorin; Brianna Lenox; Frida Ewald Sander; Ebru Aydin; Johan Aurelius; Fredrik B Thorén; Anders Ståhlberg; Svante Hermodsson; Kristoffer Hellstrand
Journal:  J Immunol       Date:  2015-04-13       Impact factor: 5.422

Review 3.  Translational mini-review series on Toll-like receptors: Toll-like receptor ligands as novel pharmaceuticals for allergic disorders.

Authors:  M Goldman
Journal:  Clin Exp Immunol       Date:  2007-02       Impact factor: 4.330

4.  Mast cells and the adaptive immune response.

Authors:  Melissa A Brown; Blayne A Sayed; Alison Christy
Journal:  J Clin Immunol       Date:  2008-09-19       Impact factor: 8.317

5.  Combined blockade of the histamine H1 and H4 receptor suppresses peanut-induced intestinal anaphylaxis by regulating dendritic cell function.

Authors:  M Wang; J Han; J Domenico; Y S Shin; Y Jia; E W Gelfand
Journal:  Allergy       Date:  2016-08-03       Impact factor: 13.146

6.  The H1 histamine receptor regulates allergic lung responses.

Authors:  Paul J Bryce; Clinton B Mathias; Krista L Harrison; Takeshi Watanabe; Raif S Geha; Hans C Oettgen
Journal:  J Clin Invest       Date:  2006-05-04       Impact factor: 14.808

Review 7.  Role of interleukin-18 in the pathophysiology of allergic diseases.

Authors:  Nathan L Sanders; Anil Mishra
Journal:  Cytokine Growth Factor Rev       Date:  2016-07-15       Impact factor: 7.638

8.  Secretory phospholipase A2 induces dendritic cell maturation.

Authors:  Laure Perrin-Cocon; Sophie Agaugué; Frédéric Coutant; Aurélie Masurel; Sofiane Bezzine; Gérard Lambeau; Patrice André; Vincent Lotteau
Journal:  Eur J Immunol       Date:  2004-08       Impact factor: 5.532

9.  FcgammaRIIb inhibits allergic lung inflammation in a murine model of allergic asthma.

Authors:  Nilesh Dharajiya; Swapnil V Vaidya; Hiroki Murai; Victor Cardenas; Alexander Kurosky; Istvan Boldogh; Sanjiv A Sur
Journal:  PLoS One       Date:  2010-02-22       Impact factor: 3.240

10.  Cytokine responses of intraepithelial lymphocytes are regulated by histamine H(2) receptor.

Authors:  Kosuke Takagaki; Satoshi Osawa; Yoshiaki Horio; Takanori Yamada; Yasushi Hamaya; Yasuhiro Takayanagi; Takahisa Furuta; Akira Hishida; Mutsuhiro Ikuma
Journal:  J Gastroenterol       Date:  2009-03-10       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.